Subscribe To
Zuora: richly priced at 31x fcf, even though it carries a lot of cash
Zuora's valuation, currently at 30x next year's free cash flow, appears relatively high for a business ...
October 6, 2023, 7:30 am
Buy joby stock now before its return flight to $10
Joby Aviation (NYSE: JOBY ) is a company that's relatively unknown today but could become a household ...
October 6, 2023, 6:40 am
Weave communications: balancing prospects and valuation with a 50x fcf
Weave Communications offers valuable software solutions for healthcare SMBs, but I have reservations about its valuation. While the company's product ...
October 6, 2023, 5:50 am
Are foreign markets the future for crocs? 1 thing investors should watch
Crocs makes plastic shoes that are relatively cheap and easy to wear. The company is largely focused on...
October 6, 2023, 5:37 am
Merlin properties: battling against a tough environment for reits
Merlin Properties has held up relatively well as far as the REIT sell-off goes, registering meaningful ...
October 5, 2023, 5:30 pm
Blackberry stock: overpriced amid spin-off and uncertainty
BlackBerry Limited stock has declined 7.5% after announcing that it will spin off its Internet of Things division. Since this division has been BlackB...
October 5, 2023, 2:50 pm
Gold prices trading near support around $1,830 as u.s. weekly jobless claims hold steady at 207k
(Kitco News) - The U.S. labor market continues to hold relatively steady with the number of workers app...
October 5, 2023, 8:37 am
Bitcoin miners see strong production increases in september
The Bitcoin mining sector has been experiencing a surge of activity recently. Companies such as Marathon Digital, Riot Platforms, and CleanSpark have ...
October 5, 2023, 6:37 am
Here's the best big pharma stock of the decade so far (and it's not even close)
There have been relatively few big winners among pharma stocks so far in the 2020s. One big pharma stoc...
October 5, 2023, 5:50 am
Time to ‘pull the brakes’ on ethereum and rotate back to bitcoin: k33 report
The relatively lackluster performance of nine new Ethereum futures exchange traded funds (ETFs) has pro...
October 5, 2023, 2:14 am
Coinbase to miss q3 revenue estimate by 10%, analyst blames low crypto volatility, volumes
Mizuho says that Coinbase will miss current consensus third-quarter revenues by 10%, citing low trading volumes. Crypto volatility has been ...
October 4, 2023, 8:20 pm
Fsd: an unorthodox strategy, but this bond cef is better than people think
First Trust High Inc Long/Short Fund offers a 12.05% current yield and employs short sales as part of its investment strategy. The FSD ETF's performan...
October 4, 2023, 5:36 pm
Down under central bank low down
Summary At their respective monetary policy meetings this week, central banks in Australia and New Zealand remained ...
October 4, 2023, 2:57 pm
Agnico eagle: too cheap to ignore
Agnico Eagle Mines is down sharply from its highs, and is a case of the proverbial baby being thrown out with the bathwater. This is because the compa...
October 4, 2023, 11:06 am
Dusa: solid earnings yield does not guarantee strong performance
Davis Select U.S. Equity ETF has an ultra-minimalist, high-conviction approach to portfolio management. It has placed the lion's share of its bets on ...
October 4, 2023, 2:19 am
Brp: strong results despite macro headwinds
The company's revenue increased by 13.9% YoY, while operating margin reached 13.6%. Despite macro uncertainty, the company's target consumer continues...
October 3, 2023, 5:32 pm
Why ralph lauren should be on your holiday wishlist
Shares of Ralph Lauren Corp NYSE: RL have been trading in a relatively narrow range for much of the pa...
October 3, 2023, 12:59 pm
Usd/jpy within touching distance of 150 as higher yields continue to pave the way
10-year yields in the US are up over 4 bps to 4.726% currently and that is continuing to keep the dollar more bid across the board. USD/JPY has been <...
October 3, 2023, 11:22 am
Light changes in market sentiment so far in european morning trade
The changes among major currencies are mostly relatively light so far on the day, outside of the antipo...
October 3, 2023, 9:05 am
Cancer drug approval? 3 biotech stocks on the brink of breakthroughs
Autologous chimeric antigen receptor T cell therapy is 0ne of the most promising, relatively new types ...
October 2, 2023, 7:09 pm